Clinical management of psoriatic arthritis in Spain: The Calipso study;Manejo clínico de la artritis psorisica en España: Estudio Calipso

Actas Dermo-Sifiliograficas

Volumn 101, Issue 7, 2010, Pages 629-636

  Lopez Estebaranz J L ^a   Zarco Montejo, P ^a   Escalas Taberner, J ^b   Garcia Rodriguez M ^c   Garcia Llorente J F ^d   Garcia Calvo C ^e  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^d HOSPITAL DE BASURTO   (Spain)

^e Departamento Mdico   (Spain)

Author keywords

Clinical practice guidelines; Patient care and management; Psoriatic arthritis

Indexed keywords

C REACTIVE PROTEIN; DICLOFENAC; ETANERCEPT; METHOTREXATE;

ADULT; AGED; ARTICLE; BODY SURFACE; CONSULTATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRESCRIPTION; PROTEIN BLOOD LEVEL; PSORIATIC ARTHRITIS; RETROSPECTIVE STUDY; RHEUMATOLOGY;

EID: 77956835925     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S1578-2190(10)70685-5     Document Type: Article

References (29)

1. D.D. Gladman Psoriatic arthritis E.D. Harris, R.C. Budd, G.S. Firestein, M.C. Genovese, J.S. Sergent, S. Ruddy, Kelly's textbook of rheumatology 7th edition 2004 Saunders Elsevier Philadelphia 1155 1164
2. D.D. Gladman, C. Antoni, P. Mease, D.O. Clegg, and P. Nash Psoriatic arthritis: epidemiology, clinical features, course, and outcome Ann Rheum Dis 64 Suppl II 2005 ii14 ii17
3. J.M. Gelfand, D.D. Gladman, P.J. Mease, N. Smith, D.J. Margolis, and T. Nijsten Epidemiology of psoriatic arthritis in the population of the United States J Am Acad Dermatol 53 2005 573 577
4. D. Reina Clasificacin de la artritis psorisica Semin Fund Esp Reumatol 10 2009 64 68
5. A. Lafont Ruzafa Tratamiento de la artropata psorisica Piel 16 2001 189 192
6. M.I. Zapico-Fernndez, and J.C. Torre-Alonso Artritis psorisica: clasificacin y evaluacin de los pacientes en la actualidad. Espondiloartropatas Reumatol Clin 1 2005 S21 S25
7. La Artritis Psorisica ¿Qu es? Sociedad Espaola de Reumatología. [consultado 29/06/2009]. Disponible en: www.ser.es/ArchivosDESCARGABLES/Folletos/09.pdf
8. J. Moll, and V. Wright Psoriatic arthritis Semin Arthritis Rheum 3 1973 55 78
9. P. Helliwell, and W. Taylor Classification and diagnostic criteria for psoriatic arthritis Ann Rheum Dis 64 Suppl II 2005 ii3 ii8
10. S. Torres-Gonzlez, and A. Aquino Ruz Artritis psorisica: cmo identificarla Rev Cent Dermatol Pascua 14 2005 62 70
11. W. Taylor, D. Gladman, P. Helliwell, A. Marchesoni, P. Mease, H. Mielants CASPAR Study Group Classification criteria for psoriatic arthritis: development of new criteria from a large international study Arthritis Rheum 54 2006 2665 2673
12. V. Chandran, C.T. Schentag, and D.D. Gladman Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting J Rheumatol 35 2008 2069 2070
13. A. Kumar, and R. Grover Management of psoriatic artritis J Indian Rheumatol Assoc 10 2002 64 68
14. J.C. Torre Alonso Opciones de tratamiento farmacolgico actuales y futuras en la artritis psorisica Rev Esp Reumatol 28 2001 382 386
15. A. Gottlieb, N.J. Korman, K.B. Gordon, S.R. Feldman, M. Lebwohl, and J.Y.M. Koo Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 2. Psoriatic arthritis: Overview and guidelines of care for treatment with an emphasis on the biologics J Am Acad Dermatol 58 2008 851 863
16. Y. El Miedany Recent developments in management of psoriatic arthritis Current Rheumatology Reviews 1 2005 9 19
17. I. Romero Crespo, R. Antn Torres, J. Borrs Blasco, and A. Navarro Ruiz Atencin farmacutica a pacientes con artritis reumatoide y psorisica en tratamiento con etanercept Farm Hosp 29 2005 171 176
18. Guas y Recomendaciones del Colegio Mexicano de Reumatología para el uso de agentes biolgicos en enfermos reumticos. Comit Mexicano del Consenso de Biolgicos Colegio Mexicano de Reumatología Reumatol Clin 2 2006 78 89
19. L. Puig, X. Bordas, J.M. Carrascosa, E. Daudn, J.M. Ferrndiz, and J.L. Lpez Estebaranz Documento de consenso sobre la evaluacin y tratamiento de la psoriasis moderada/grave del grupo Espaol de Psoriasis de la Academia Espaola de Dermatologa y Venereologa Actas Dermosifiliogr 100 2009 277 286
20. E.M. Ruderman Current Perspectives in the Recognition and Management of Psoriatic Arthritis: Implications for Integrated Patient Care Am J Manag Care 8 2002 S171 S180
21. G.G. Krueger Clinical features of psoriatic arthritis Am J Manag Care 8 2002 S160 S170
22. M.A. Radtke, K. Reich, C. Blome, S. Rustenbach, and M. Augustin Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey J Eur Acad Dermatol Venereol 23 2009 68 91
23. Rigopoulos D, Gregoriou S, Katrinaki A, Korfitis C, Larios G, Stamou C, et al. Characteristics of psoriasis in Greece: an epidemiological study of a population in a sunny Mediterranean climate. Eur J Dermatol 2010;Feb 2 (Epub ahead of print)
24. J. Hermoza Rodrguez, and F. Villanueva Vilchez Psoriasis y hallazgos de artropata inflamatoria en la Clnica. Chincha Es Salud Lima Dermatol Per 14 2004 21 29
25. K. Reich, K. Kreger, R. Mssner, and M. Augustin Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis Br J Dermatol 160 2009 1040 1047
26. P. Gisondi, G. Girolomoni, F. Sampogna, S. Tabolli, and D. Abeni Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis Eur J Dermatol 15 2005 279 283
27. P.S. Yamauchi, V. Gindi, and N.J. Lowe The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety Dermatol Clin 22 2004 449 459
28. L. Puig, J.M. Carrascosa, E. Daudn, J.L. Snchez-Carazo, C. Ferrndiz, and M. Snchez-Regaa Directrices espaolas basadas en la evidencia para el tratamiento de la psoriasis moderada a grave con agentes biolgicos Actas Dermosifiliogr 100 2009 386 413
29. E. Collantes, J.L. Fernndez, R. García-Vicua, J. Gratacs, J. Mulero, and S. Muoz Actualizacin del Consenso de la Sociedad Espaola de Reumatología sobre el uso de antagonistas del TNF-α en las espondiloartritis, incluida la artritis psorisica Reumatol Clin 3 Supl 2 2007 S61 S71